Introduction: is hypertension a metabolic disease?

Keywords

Medicine, Blood pressure, Dyslipidemia, Internal medicine, Risk factor

References

• The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study.J Stokes, Kannel Wb, Philip A. Wolf — 1987
• Serum Cholesterol, Blood Pressure, Cigarette Smoking, and Death From Coronary Heart Disease Overall Findings and Differences by Age for 316099 White MenJames D. Neaton — 1992
• Excess smoking in malignant-phase hypertensionC. Isles, J. J. Brown, A. M. M. Cumming — 1979
• Elevation of ambulatory systolic blood pressure in hypertensive smokers. A case-control study.Samuel J. Mann — 1991
• Management of elderly patients with sustained hypertension.K. Beard, CJ Bulpitt, H. Mascie-Taylor — 1992
• Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias.Stephen MacMahon — 1990
• Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.Michaela Modan, Hillel Halkin, Shlomo Almog — 1985
• Controlled Clinical Trials of Drug Treatment for Hypertension A ReviewJ A Cutler, Stephen MacMahon, Curt D. Furberg — 1989
• Insulin resistance in essential hypertension.Eleuterio Ferrannini, G. Buzzigoli, Riccardo C. Bonadonna — 1987

Cited by

• Pharmacotherapy for hypertension in the elderlyCynthia D. Mulrow, Joseph Lau, John A. Cornell — 1998
• Coexistence of lipid disorders and arterial hypertension in the population of 50 year old subjectsMaria Gnacińska, Tomasz Zdrojewski, Łukasz Wierucki — 2004
• Safety and Tolerability of Moxonidine in the Treatment of HypertensionMichael Schächter, Joachim Luszick, Bodo J ger — 1998
• Hypertension in the Elderly Implications and Generalizability of Randomized TrialsCynthia D. Mulrow — 1994

Related papers

• Preventing Left Ventricular Hypertrophy by ACE Inhibition in Hypertensive Patients With Type 2 DiabetesPiero Ruggenenti, Ilian Iliev, Grazia Maria Costa — 2008
• Thrombogenic Risk Factors for Cardiovascular Disease in Dialysis PatientsBruce F. Culleton, Peter W.F. Wilson — 1999
• Contribution of Vascular Risk Factors to Dementia and Dementia Risk Prediction Varies Across Mid-to Later-Life: The Framingham Heart Study (P1-1.Virtual)Emer R. McGrath, Alexa Beiser, Adrienne O’Donnell — 2022
• State of the art coronary heart disease risk estimations based on the Framingham heart study.Jindra Reissigová, Marie Tomečková — 2005
• Description of the Framingham Heart Study data for Genetic Analysis Workshop 13L. Adrienne Cupples, Qiong Yang, Serkalem Demissie — 2003
• The Framingham Study: The Epidemiology of Atherosclerotic DiseaseRobert I. Levy — 1981
• Methods to identify increased risk of coronary disease in the general population: conclusion is oversimplification.Gerd Assmann, Paul Cullen, Helmut Schulte — 2003
• Serum Uric Acid and Cardiovascular Disease RiskBruce F. Culleton, Martin G. Larson, Daniel Levy — 2000
• Research on the statistical analysis methods of heart disease: taking the Framingham Heart Study as an exampleJieyu Guo — 2022